You just read:

Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine

News provided by

Bellicum Pharmaceuticals, Inc.

Feb 18, 2011, 08:09 ET